Skip to content

Irregular and scanty menses improvement with Lashun Kalk in Artavkshay with special reference to Oligohypomenorrhea.

To assess the effect of Lashunkalk in the management of Artavkshay with special reference to oligohypomenorrhea-A single arm clinical study

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039423
Enrollment
36
Registered
2022-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Sponsors

Dr Meenakshi Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient fulfilling diagnostic criteria for Artavkshay. 2.Both married and unmarried women. 3.patients between age group 16yrs to 40 yrs

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women. 2.k/c/o Thyroid dysfunction,Kochs,DM,HTN,Vascular (bleding)disorder. 3.Hb count 4.congenital anomalies and malignacy of reproductive System

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Lashunkalk in the management of Artavkshay with special reference to oligohypomenorrhea.Timepoint: Treatment will be given from 4th day of menses for 30 days for 3 consecutive cycle, follow up after each month

Secondary

MeasureTime frame
1 To study the complete literature available on Artavkshay. 2.To observe the effect of Lashun on ovarian hormones. 3.To propose the safe, cost effective, easily available,palatable an ayurvedic regimen in management of Artavkshay by using Laashun Kalk. 4.To study side effect if occurs any.Timepoint: Treatment will be given from 4th day of menses for 30 days for 3 consecutive cycle, follow up after each month

Countries

India

Contacts

Public ContactDr Pranali N Dandekar

YMT Ayurvedic medical college and hospital

singhmeenu3896@gmail.com8356953015

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026